COVID-19 Vaccine

Advances in Infectious Diseases

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.org/journal/aid
E-mail: aid@scirp.org

Google-based Impact Factor: 1.61
Citations

Journals Menu

"COVID-19 Vaccine"
written by Zameer Shervani, Intazam Khan, Tasrina Khan, Umair Yaqub Qazi,
published by Advances in Infectious Diseases, Vol.10 No.3, 2020

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	The effect of music to encourage responsible health-related behaviours among reluctant tourists: analysis of high–and low-context cultures
	García, CM Sabiote-Ortiz… - Current Issues in …, 2024

[2]	I want to be safe: understanding the main drivers behind vaccination choice throughout the pandemic
	BMC Public Health, 2024

[3]	COVID-19 Aftereffects (Long COVID) Associated with Wuhan, Delta, and Omicron Variants Reported in Japanese Hospitals
	… Journal of Medical …, 2024

[4]	COVID-19 and progress in therapeutic approaches: a narrative review
	Cukurova Medical …, 2024

[5]	Unveiling the Impact of Homogenous Vaccines on Clinical Symptoms and Risk Factors Following the SARS-CoV-2 Infection
	Int J Enteric …, 2023

[6]	Navigating the horizon of mRNA vaccines: Tracing their evolution, ensuring safety, and unveiling therapeutic potential.
	… E-Journal of …, 2023

[7]	4th Serosurvey of Tamil Nadu: Infection and Vaccine Generated Hybrid Immunity
	European Journal of …, 2023

[8]	COVID-19 Vaccines Hesitancy among Universities Staff in the Kurdistan Region/Iraq: A Cross-Sectional Study
	Polytechnic …, 2023

[9]	Knowledge, attitude, and perceptions of the public toward the COVID-19 vaccine: A cross-sectional study from India
	Journal of Applied …, 2023

[10]	ATTITUDE OF THE MEDICAL PUBLIC TO VACCINATION AND COVID-19 IN VACCINATED POPULATION
	СМОЛЕНСКИЙ МЕДИЦИНСКИЙ АЛЬМАНАХ, 2022

[11]	Prospects and Challenges of Utilizing Solar Energy for the COVID-19 Vaccine Cold Storage in Remote Clinics of Tropical Countries
	Energy Engineering, 2022

[12]	COVID‐19 in the news: The first 12 months
	International Journal of Applied …, 2022

[13]	COVID-19 in Karnataka: Rise of Omicron
	European Journal of …, 2022

[14]	COVID-19 Vaccine and the Necessity to Identify Its Side Effects
	Journal of Health …, 2022

[15]	Prevalence and Pathogenicity of Omicron Varian
	European Journal of …, 2022

[16]	A Review: Severe Treatments, Drug and Vaccine studies for Coronavirus Disease (COVID 19)
	Journal of Scientific Reports-C, 2022

[17]	4th National Sero Survey of India: vaccine generated antibodies enhancement
	European Journal of …, 2022

[18]	An IoT/FOG based framework for sports talent identification in COVID-19 like situations
	International Journal of Information …, 2022

[19]	Future of hydrogen as an alternative fuel for next-generation industrial applications; Challenges and expected opportunities
	Energies, 2022

[20]	Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection
	Journal of Medical …, 2022

[21]	5th and 6th Sero Survey of Delhi: Vaccine Activated Antibodies Enhancement
	European Journal of …, 2022

[22]	Exploring the determinants of influenza A/H7N9 control intervention efficacy in China: Disentangling the effect of the '1110'policy and poultry vaccination
	Transboundary and …, 2022

[23]	The Omicron Wave in India, Mumbai, and Delhi: Prevalence and Pathogenicity
	European Journal of …, 2022

[24]	The Omicron Variant: Prevalence, Transmissibility, and Pathogenicity
	European Journal of …, 2022

[25]	Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity
	European Journal of …, 2022

[26]	Gambaran Kipi (Kejadian Ikutan Pasca Imunisasi) Pada Karyawan Rumah Sakit yang Mendapatkan Imunisasi Dengan Vaksin Sinovac di RSUD Kota Yogyakarta
	Majalah Farmaseutik, 2021

[27]	Single-cell transcriptomic atlas of individuals receiving inactivated COVID-19 vaccines reveals distinct immunological responses between vaccine and natural SARS …
	medRxiv, 2021

[28]	Examining Bangladesh's responses to COVID-19 in light of Vietnam: Lessons learned
	Global …, 2021

[29]	Novel cascade refrigeration cycle for cold supply chain of COVID-19 vaccines at ultra-low temperature-80° C using ethane (R170) based hydrocarbon pair
	World Journal of Engineering and …, 2021

[30]	COVID-19 infection in 8 big cities of India: The Dynamics of the Spread and Seropositivity
	European Journal of …, 2021

[31]	COVID-19 Infection in India: Seropositivity versus the Dynamics of the Spread
	European Journal of Medical and …, 2021

[32]	A comprehensive summary of the knowledge on COVID-19 treatment
	2021

[33]	Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa
	2021

[34]	Viability of SARS-CoV-2 and Sanitization Methods
	2021

[35]	COVID-19 in Kerala: Health Index Theory
	2021

[36]	Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals
	2021

[37]	The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
	2021

[38]	Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity
	2021

[39]	Sistem Prediksi Jumlah Kasus Covid-19 di Jakarta Menggunakan Metode Linear Regression
	PROSIDING SEINASI …, 2021

[40]	ANALIZA VPLIVA PANDEMIJE COVIDA-19 NA TURISTIČNO

[1]	4th Serosurvey of Tamil Nadu: Infection and Vaccine Generated Hybrid Immunity European Journal of Medical and Health Sciences, 2023 DOI:10.24018/ejmed.2023.5.2.1525

[2]	COVID-19 in Karnataka: Rise of Omicron European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.6.1503

[3]	Prospects and Challenges of Utilizing Solar Energy for the COVID-19 Vaccine Cold Storage in Remote Clinics of Tropical Countries: Review Energy Engineering, 2022 DOI:10.32604/ee.2022.019200

[4]	5th and 6th Sero Survey of Delhi: Vaccine Activated Antibodies Enhancement European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.1.1152

[5]	4th National Sero Survey of India: Vaccine Generated Antibodies Enhancement European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.1.1132

[6]	Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.2.1173

[7]	Omicron Variant: Prevalence, Transmissibility, and Pathogenicity European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.3.1258

[8]	Future of Hydrogen as an Alternative Fuel for Next-Generation Industrial Applications; Challenges and Expected Opportunities Energies, 2022 DOI:10.3390/en15134741

[9]	Omicron Wave in India, Mumbai, and Delhi: Prevalence and Pathogenicity European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.3.1376

[10]	An IoT/FOG based framework for sports talent identification in COVID-19 like situations International Journal of Information Technology, 2022 DOI:10.1007/s41870-022-00984-z

[11]	Exploring the determinants of influenza A/H7N9 control intervention efficacy in China: Disentangling the effect of the ‘1110’ policy and poultry vaccination Transboundary and Emerging Diseases, 2022 DOI:10.1111/tbed.14532

[12]	Prevalence and Pathogenicity of Omicron Varian European Journal of Medical and Health Sciences, 2022 DOI:10.24018/ejmed.2022.4.5.1511

[13]	Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa European Journal of Medical and Health Sciences, 2021 DOI:10.24018/ejmed.2021.3.1.684

[14]	Viability of SARS-CoV-2 and Sanitization Methods European Journal of Medical and Health Sciences, 2021 DOI:10.24018/ejmed.2021.3.1.665

[15]	The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations Viruses, 2021 DOI:10.3390/v13061109

[16]	A Comprehensive Summary of the Knowledge on COVID-19 Treatment Aging and disease, 2021 DOI:10.14336/AD.2020.1124

[17]	Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals International Journal of Production Economics, 2021 DOI:10.1016/j.ijpe.2021.108193

[18]	COVID-19 Infection in 8 Big Cities of India: The Dynamics of the Spread and Seropositivity European Journal of Medical and Health Sciences, 2021 DOI:10.24018/ejmed.2021.3.6.985

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Infectious Diseases

Advances in Infectious Diseases

Journals Menu

Home

About SCIRP

Service

Policies